XBiotech operates as a fully integrated international biosciences corporation committed to leading the exploration, advancement, and marketing of therapeutic antibodies utilizing its True Human™ patented technology. XBiotech's True Human™ antibodies, obtained from individuals with innate immunity to specific diseases, are completely human, setting them apart from earlier antibody treatments. Through its exploration and clinical initiatives spanning various disease categories, XBiotech's True Human™ antibodies hold the potential to utilize the body's natural immunity to combat diseases with heightened safety, effectiveness, and tolerability.